Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | -1.83% | -13.37% | -44.71% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- MarketScreener Strategies